538965 (1)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE notifies listing of 31,75,000 new equity shares of Concord Drugs Limited on preferential basis, effective April 21, 2026, with lock-in … | |||||||||||||||
BSE notifies listing of 31,75,000 new equity shares of Concord Drugs Limited on preferential basis, effective April 21, 2026, with lock-in periods until October 2026 and October 2027.
| |||||||||||||||